Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

668
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
668
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.0K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.7K
Leaky Scanning02:28

Leaky Scanning

5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of a New Scaffold RSK2 Inhibitor With Virtual and Phenotypical Screening.

ChemMedChem·2026
Same author

Design, synthesis, and evaluation of 4-(aminomethyl)-2-(phenylamino)pyridine derivatives as novel lysyl oxidase-like 2 inhibitors against metastatic melanoma.

Bioorganic & medicinal chemistry·2026
Same author

DeepCYP: an integrated deep learning web server for the holistic "pathway-site product" prediction of CYP450 metabolism.

Nucleic acids research·2026
Same author

A Prospective, Multicenter, Randomized, Assessor-Blinded Study Assessing the Efficacy and Safety of Injectable Non-Cross-Linked Hyaluronic Acid for Improving Facial Skin Rejuvenation.

Clinical, cosmetic and investigational dermatology·2026
Same author

Copper-rhein nanozymes induce bacterial activation-exhaustion death for the treatment of bacterial pneumonia and infected wounds.

Journal of nanobiotechnology·2026
Same author

CryoSIP: unleashing protein high-resolution Cryo-EM via semantic-instance collaborative picking.

Briefings in bioinformatics·2026

Related Experiment Video

Updated: Jun 11, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

DrugReAlign: a multisource prompt framework for drug repurposing based on large language models.

Jinhang Wei1, Linlin Zhuo2, Xiangzheng Fu3

  • 1School of Data Science and Artificial Intelligence, Wenzhou University of Technology, Wenzhou, 325027, China.

BMC Biology
|October 8, 2024
PubMed
Summary

This study introduces DrugReAlign, a novel framework using large language models (LLMs) for efficient drug repurposing. DrugReAlign enhances drug discovery by leveraging LLMs and multi-source prompts to overcome data limitations in predicting drug-target interactions.

Keywords:
Drug repositioningDrug-target interactionsLarge Language ModelMolecular docking

More Related Videos

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

508
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Related Experiment Videos

Last Updated: Jun 11, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

508
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Artificial intelligence in drug discovery

Background:

  • Drug repurposing offers efficient and cost-effective drug discovery.
  • Traditional drug-target interaction (DTI) models face limitations in broad molecular spaces due to data and parameter constraints.
  • Large language models (LLMs) show promise for drug repurposing due to their scale and extensive training data.

Purpose of the Study:

  • To introduce DrugReAlign, a novel LLM-based framework for efficient drug repurposing.
  • To overcome data availability limitations in traditional DTI prediction models.
  • To enhance LLM performance in drug repurposing using multi-source prompt techniques.

Main Methods:

  • Developed DrugReAlign, a framework integrating LLMs with multi-source prompt techniques.
  • Utilized LLMs to acquire general knowledge about drugs and targets from human knowledge bases.
  • Incorporated target summaries and target-drug interaction data as multi-source prompts to improve LLM performance.
  • Validated the framework using molecular docking and DTI datasets.

Main Results:

  • DrugReAlign demonstrated efficiency and reliability in drug repurposing.
  • Multi-source prompts significantly improved LLM performance in predicting drug-target interactions.
  • A direct correlation was observed between LLM target analysis accuracy and prediction quality.

Conclusions:

  • DrugReAlign effectively leverages LLMs and multi-source prompts for enhanced drug repurposing.
  • The framework overcomes limitations of traditional DTI prediction models.
  • Findings suggest LLM accuracy in target analysis is crucial for successful drug repurposing, potentially heralding a new paradigm.